SCHEMBL22435151

SCHEMBL22435151

CCCCC(CC)c1ccc(OC)c(OC)c1OC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 3/20 0.43
TOP1 P11387 4/20 0.39
TSHR P16473 1/20 0.35
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
PDE4D Q08499 1/20 0.34
DHFR P00374 1/20 0.33
EGFR P00533 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
PDE1A P54750 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE1C Q14123 1/20 0.33
ALOX5 P09917 1/20 0.33
SMAD3 P84022 1/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22571314 0.90 AOC3 (0.45) AOC3SMN1; SMN2PDE1APDE1BPDE1C
SCHEMBL27587124 0.87 AOC3 (0.43) AOC3TOP1ALOX5
SCHEMBL14399554 0.86 AOC3 (0.50) AOC3SMN1; SMN2PDE1APDE1BPDE1C
SCHEMBL27692331 0.82 AOC3 (0.44) AOC3TOP1LMNAMAPTKMT2A
SCHEMBL28309046 0.81 SMN1; SMN2 (0.42) TOP1TSHRMAPTDHFREGFR
SCHEMBL31195739 0.79 AOC3 (0.44) AOC3TOP1
SCHEMBL23920671 0.76 AOC3 (0.42) AOC3TOP1LMNAALOX5
SCHEMBL23920596 0.75 AOC3 (0.46) AOC3KMT2ASMN1; SMN2ALOX5TAS1R3
SCHEMBL22571301 0.74 AOC3 (0.49) AOC3TSHRLMNAMAPTPDE1A
SCHEMBL22432025 0.72 TOP1 (0.34) TOP1TSHRDHFREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11505528-B2 Inhibitors of microbially induced amyloid AXIAL THERAPEUTICS, INC. (US) 2022-11-22 US disclosed
US-20200290970-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL BIOTHERAPEUTICS, INC. (US) 2020-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11505528-B2 Inhibitors of microbially induced amyloid SNCA, PARK7, PRNP AOC3 1883/4885TOP1 4602/4885TSHR 4566/4885
US-20200290970-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID SNCA, PARK7, PRNP AOC3 1883/4885TOP1 4602/4885TSHR 4566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.